Effects of haloperidol on Kv4.3 potassium channels

Hong Joon Lee1, Ki-Wug Sung1, Sang June Hahn2

  • 1Department of Pharmacology, Cell Death and Disease Research Center, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, , Seoul 137-701, Republic of Korea.

Insights

Haloperidol, used for psychosis, affects Kv4.3 potassium channels by accelerating inactivation and causing a concentration-dependent block. This impacts cardiac function, potentially explaining cardiovascular events associated with the drug.

Area of Science:

  • Cardiovascular Pharmacology
  • Ion Channel Physiology
  • Neuropharmacology

Background:

  • Haloperidol is a widely used antipsychotic medication.
  • Adverse cardiovascular events are a known risk associated with haloperidol treatment.
  • Understanding the molecular mechanisms underlying these events is crucial for patient safety.

Purpose of the Study:

  • To investigate the direct effects of haloperidol on Kv4.3 potassium currents.
  • To elucidate the specific interactions between haloperidol and Kv4.3 channel kinetics.
  • To determine the concentration-dependent effects and potential mechanisms of haloperidol-induced channel modulation.

Main Methods:

  • Whole-cell patch-clamp technique was employed to record Kv4.3 currents in stably transfected CHO cells.
  • Concentration-response relationships were analyzed for haloperidol's effects on current amplitude and kinetics.
  • Voltage-dependence of activation and inactivation, as well as recovery from inactivation, were assessed.

Main Results:

  • Haloperidol did not significantly inhibit the peak amplitude of Kv4.3 currents.
  • Haloperidol accelerated the inactivation and activation decay rates of Kv4.3 in a concentration-dependent manner.
  • A concentration-dependent decrease in Kv4.3 current integral (IC50 = 3.6 μM) was observed, alongside a use-dependent block and slowed recovery from inactivation.

Conclusions:

  • Haloperidol modulates Kv4.3 channel function by accelerating inactivation and activation kinetics.
  • The drug exhibits a concentration-dependent block, affecting both open and closed states of the Kv4.3 channel.
  • These findings provide insights into the potential electrophysiological basis for haloperidol's cardiovascular side effects.

Related Concept Videos

Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
11.2K
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

7.6K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.9K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
1.0K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.7K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
4.2K